LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹8.11 Cr | ₹7.67 Cr | ₹0.70 Cr | ₹-1.88 Cr | ₹-4.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹8.11 Cr |
| Mar2025 | ₹7.67 Cr |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹-1.88 Cr |
| Mar2022 | ₹-4.50 Cr |
How is Net Cash Inflow / Outflow of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.11 Cr | 5.80 | |
| Mar2025 | ₹7.67 Cr | 1,003.17 | |
| Mar2024 | ₹0.70 Cr | Positive | |
| Mar2023 | ₹-1.88 Cr | Negative | |
| Mar2022 | ₹-4.50 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,028.4 Cr | -0.9% | -10.1% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -0.9% |
-10.1% |
-3.3% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses